Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation

Diabetic Medicine - Tập 23 Số 5 - Trang 469-480 - 2006
K. G. M. M. Alberti1, Paul Zimmet1, Jonathan E. Shaw1
1Department of Endocrinology and Metabolic Medicine, St Mary's Hospital, London, UK and International Diabetes Institute, Caulfield, Australia

Tóm tắt

AbstractAims  To establish a unified working diagnostic tool for the metabolic syndrome (MetS) that is convenient to use in clinical practice and that can be used world‐wide so that data from different countries can be compared. An additional aim was to highlight areas where more research into the MetS is needed.Participants  The International Diabetes Federation (IDF) convened a workshop held 12–14 May 2004 in London, UK. The 21 participants included experts in the fields of diabetes, public health, epidemiology, lipidology, genetics, metabolism, nutrition and cardiology. There were participants from each of the five continents as well as from the World Health Organization (WHO) and the National Cholesterol Education Program—Third Adult Treatment Panel (ATP III). The workshop was sponsored by an educational grant from AstraZeneca Pharmaceuticals.Consensus process  The consensus statement emerged following detailed discussions at the IDF workshop. After the workshop, a writing group produced a consensus statement which was reviewed and approved by all participants.Conclusions  The IDF has produced a new set of criteria for use both epidemiologically and in clinical practice world‐wide with the aim of identifying people with the MetS to clarify the nature of the syndrome and to focus therapeutic strategies to reduce the long‐term risk of cardiovascular disease. Guidance is included on how to compensate for differences in waist circumference and in regional adipose tissue distribution between different populations. The IDF has also produced recommendations for additional criteria that should be included when studying the MetS for research purposes. Finally, the IDF has identified areas where more studies are currently needed; these include research into the aetiology of the syndrome.

Từ khóa


Tài liệu tham khảo

Kylin E, 1923, Zentralblatt Fuer Innere Med, 44, 105

Vague J, 1947, Presse Medl, 53, 339

10.2337/diab.37.12.1595

10.1001/archinte.1989.00390070054005

10.2337/diab.41.6.715

World Health Organization., 1999, Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications.

10.1046/j.1464-5491.1999.00059.x

10.1001/jama.285.19.2486

10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S

10.1016/0002-9149(94)90676-9

American College of Endocrinology Task Force on the Insulin Resistance Syndrome., 2003, Endocr Pract, 9, 236

10.2337/diacare.25.5.829

10.1001/archinte.164.10.1066

10.1161/01.CIR.0000140762.04598.F9

10.2337/diacare.26.11.3153

10.1093/aje/kwf145

10.2337/diacare.27.11.2676

10.1016/j.ecl.2004.03.005

Last JM, 1995, A Dictionary of Epidemiology, 180

10.1001/jama.1993.03510230061036

Ohlson LO, 1985, Diabetes, 34, 1055, 10.2337/diab.34.10.1055

10.1001/jama.280.21.1843

10.1097/01.mol.0000137237.97341.fd

10.1161/01.ATV.20.8.1932

10.2337/diacare.27.5.1182

10.1016/S0026-0495(03)00196-3

10.1161/01.CIR.97.10.996

10.1210/jc.2004-0432

10.1038/sj.ijo.0802496

10.1161/01.ATV.21.6.961

10.1001/jama.287.3.356

10.1016/j.ecl.2004.03.008

10.1056/NEJM199103143241105

10.1038/sj.ijo.0801837

10.1146/annurev.publhealth.22.1.355

10.3109/07853899808999404

10.1001/jama.288.14.1723

10.1016/S0140-6736(99)04021-0

10.1038/414782a

10.1093/oxfordjournals.aje.a009158

10.2337/diabetes.53.8.2087

10.1016/0021-9150(94)90025-6

10.1161/01.ATV.0000099786.99623.EF

10.1007/s11892-004-0074-9

10.2337/diabetes.47.10.1643

Nesto RW, 2003, Rev Cardiovasc Med, 4, S11

10.1161/01.CIR.0000112379.88385.67

10.1007/s00125-004-1335-5

10.2337/diacare.24.4.683

10.1001/jama.288.21.2709

10.2337/diacare.28.2.385

10.1161/01.CIR.0000080897.52664.94

10.2337/diacare.26.5.1513

10.1093/aje/kwf111

10.2337/diacare.25.1.43

10.1007/s00125-004-1334-6

10.1136/bmj.311.6998.158

10.1136/bmj.311.7017.1401

World Health Organization., 1997, Obesity: Preventing and Managing the Global Epidemic.

10.1093/ajcn/80.5.1129

10.1038/sj.ijo.0802040

10.1046/j.1467-789X.2002.00067.x

Zhou BF, 2002, Biomed Environ Sci, 15, 83

10.2337/diacare.26.5.1380

10.1253/circj.66.987

10.2337/diacare.26.12.3230

10.1056/NEJM200105033441801

10.1161/01.HYP.0000107251.49515.c2

10.1056/NEJMoa012512

10.2337/diabetes.51.9.2796

10.1111/j.1462-8902.2004.0348.x

10.1016/S0140-6736(02)08905-5

10.2337/diacare.27.1.155

10.1016/S0140-6736(98)07037-8

UKPDS Group., 1998, Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6

10.1001/jama.290.4.486

10.2337/diacare.27.2007.S15

Balkau B, 2002, Diabet Metab, 28, 364

10.1016/S1262-3636(07)70067-8

Cameron AJ, 2003, Atherosclerosis, 46, A3068

Thông tin
Thông tin xuất bản

Diabetic Medicine

Tập 23 Số 5

469-480

Thông tin tác giả